What is Unicon Sciences?
Unicon Sciences operates as a premier consultancy, providing specialized services to the pharmaceutical, biotechnology, and medical device industries. The firm's expertise spans critical areas including regulatory affairs, pharmacovigilance, compliance, and validation, all aimed at accelerating drug discovery and development pipelines. By fostering strategic partnerships, Unicon Sciences delivers top-tier solutions designed to improve patient health outcomes globally.
How much funding has Unicon Sciences raised?
Unicon Sciences has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for Unicon Sciences?
The substantial late-stage funding indicates Unicon Sciences is poised for significant expansion and further market penetration. This capital infusion is expected to fuel strategic initiatives, potentially including service portfolio enhancement, geographic reach expansion, and further investment in technological capabilities to maintain its competitive edge in the highly regulated life sciences consulting space. The company's focus on improving patient quality of life globally suggests a continued commitment to impactful solutions.
See full Unicon Sciences company page
